QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 desantis-administration-cautions-against-pfizer-moderna-mrna-covid-vaccines-for-vulnerable-individuals-cites-concerns-related-to-rare-heart-conditions

Florida advises against mRNA Covid vaccines for vulnerable residents, citing safety concerns. Gov. DeSantis' administration...

Core News & Articles

https://www.nbcnews.com/health/health-news/florida-covid-shots-mrna-vaccines-older-adults-rcna170997Even as the Covid wave in F...

 does-of-novavax-2024-2025-formula-covid-19-vaccine-available-across-us

Doses of Novavax's 2024-2025 Formula COVID-19 vaccine now available at thousands of locations nationwideNovavax's updat...

 why-are-novavax-shares-trading-lower-today

Novavax Inc. (NASDAQ: NVAX) shares are trading lower Thursday following multiple significant announcements. Here's what you...

 fda-approves-novavaxs-updated-covid-vaccine-targeting-currently-circulating-variants

The FDA granted Emergency Use Authorization to Novavax's updated COVID-19 vaccine for individuals aged 12 and older. The va...

 novavax-2024-2025-formula-covid-19-vaccine-now-authorized-and-recommended-for-use-in-the-us

Novavax expects pre-filled syringes will be broadly available in thousands of locations across the U.S.Novavax's vaccine is...

 novavax-says-fda-authorizes-updated-covid-19-vaccine-to-better-protect-against-currently-circulating-variants

- Reuters 

Core News & Articles

- Press Conference

 us-fda-official-says-cant-comment-on-novavax-covid-19-vaccine-but-says-the-agency-would-take-rapid-action-once-they-receive-data

- Reuters

 fda-approves-updated-covid-vaccines-from-pfizer-and-moderna-but-leaves-out-novavaxs-shot

The FDA granted emergency use authorization for updated mRNA COVID-19 vaccines targeting the Omicron KP.2 strain, including new...

 novavax-continues-to-work-with-the-us-fda-on-authorization-of-2024-2025-formula-covid-19-vaccine-expect-to-have-authorization-for-2024-2025-formula-covid-19-vaccine-in-time-for-peak-vaccination-season

- Reuters

Core News & Articles

- Reuters 

 fda-set-to-approve-covid-19-vaccines-as-soon-as-this-week-stocks-etfs-to-watch

The FDA may approve updated COVID-19 vaccines this week to combat recent strains as the country endures a significant summer ou...

 b-riley-securities-reiterates-buy-on-novavax-lowers-price-target-to-23

B. Riley Securities analyst Mayank Mamtani reiterates Novavax (NASDAQ:NVAX) with a Buy and lowers the price target from $25 ...

 jp-morgan-maintains-underweight-on-novavax-raises-price-target-to-9

JP Morgan analyst Eric Joseph maintains Novavax (NASDAQ:NVAX) with a Underweight and raises the price target from $8 to $9.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION